Bet­ter Ther­a­peu­tics cuts 35% of staff while await­ing dig­i­tal ther­a­peu­tic ap­proval

Dig­i­tal ther­a­peu­tics com­pa­ny Bet­ter Ther­a­peu­tics an­nounced on Thurs­day that it’s cut­ting 35% of its staff as it awaits FDA clear­ance for its first prod­uct.

The com­pa­ny, which launched eight years ago, is one of a grow­ing group of com­pa­nies seek­ing a dig­i­tal al­ter­na­tive to tra­di­tion­al med­i­cine. The space saw a record $7.5 bil­lion in in­vest­ments in 2021, ac­cord­ing to Chris Doko­ma­ji­lar at Deal­For­ma, with us­es span­ning AD­HD, PTSD and oth­er in­di­ca­tions. How­ev­er, pri­vate in­sur­ers have been slow to hop on board.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER